Latest news
ACAD: Q2 revenue rose 17% to $308M, with DAYBUE and NUPLAZID driving strong growth and guidance raised - TradingViewTradingView · Tue, 04 Aug 2026 22:42:33 GMTACADIA Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Tue, 04 Aug 2026 22:03:55 GMTAcadia Pharmaceuticals Reports Second Quarter 2026 Financial Results - Business WireBusiness Wire · Tue, 04 Aug 2026 20:05:00 GMT